Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$27.17 +0.97 (+3.70%)
As of: Nov 10, 2026 · 2:38 PM EST

Arcutis Biotherapeutics (ARQT) EV to EBITDA (2024)

Updated

Arcutis Biotherapeutics' EV to EBITDA was 84.18 in Q2 2024.

Analysis

Arcutis Biotherapeutics (ARQT) EV to EBITDA (2024) Analysis & Trends

On a trailing twelve-month basis, Arcutis Biotherapeutics' EV to EBITDA was 18.90 through Jun 30, 2024.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Arcutis Biotherapeutics 3.53 Bn 2.65 Bn 131.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 84.18
API Access

Arcutis Biotherapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ARQT&period=max&api_key=YOUR_API_KEY